#surgline

With the RECORD Volume CNUV ran right and never looked back. Sure the stock saw its profit taking but each small dip their was an opportunity to buy on this squeeze and the shorts looked like they were covering hard.

CNUV's Extensive Leadership. CNUV is not being ran by typical penny stock players. This is the start of something much larger. With these type of players that have extensive SUCCESS in the medical industry with other MEDICAL ENDEAVORS, this is not their first ball game. These people also own a great deal of CNUV stock and i imagine have a very good idea of the success they are capable of.

China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that it has completed the acquisition of 100% of the common stock of SurgLine, Inc. ("SurgLine"). Pursuant to the terms of the Share Exchange Agreement SurgLine will become a wholly owned subsidiary of China Nuvo. The Company will continue to trade under the symbol CNUV. At the appropriate time the Company will seek to change its name and symbol to reflect the business of SurgLine. SurgLine's product lines include trauma, orthopedic, spine and ENT medical and surgical products selling into hospitals and surgery centers. SurgLine, formed earlier this year and in business for a few months already is generating revenues and orders as previously reported.